8-K/A XBRL

FORM 8-K/A

Company: VYNE Therapeutics Inc.
Filed: January 14, 2022
Period of Report: January 12, 2022
Accession Number: 0001104659-22-004497

View Document ↗ View on SEC.gov ↗